左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.

Slides:



Advertisements
Similar presentations
TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.
Advertisements

IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
A multicenter, randomized, prospective DKCRUSH-III study
Bifurcation coronary stenting: State 0f the Art Mazhar M Khan Consultant Cardiologist Royal Victoria Hospital Belfast, N.Ireland.
BIFURCATION LESIONS Dr. Tahsin.N
Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.
Randomized Comparison of FFR-guided and Angiography-guided Provisional Stenting for True Coronary Bifurcation Lesions: The DKCRUSH-VI trial Shao-Liang.
Optimal Stent Expansion and Optimization
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
Bifurcation Stenting: A primer
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Multi-vessel disease and intracoronay physiology Combat MI 2009 Kees-joost Botman MD, PhD Catharina hospital Eindhoven Heart Institute The Netherlands.
BURZOTTA F. 1, PAN M. 2 (CO-FIRST AUTHOR), TRANI C. 1, MEDINA A. 3, SUÀREZ DE LEZO J. 2, NICCOLI G. 1, ROMERO M. 2, PORTO I. 1, MAZUELOS F. 2, LEONE A.M.
PCI in Left Main Coronary Bifurcation Disease -Step Mini Crush
IVUS evaluation TAP technology for unprotected left main bifurcation lesions interventional therapy Yong-Sheng Ke. MD Department of Cardiology, Yijishan.
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
Left Main Stem Intervention Trials & Registries Keith D. Dawkins MD FRCP FACC Southampton University Hospital UK.
LM strategy Interventional cardiology dpt Cardiovascular Hospital - Lyon - France Gilles Rioufol MD PhD INSERM U1060 High Tech Marseille, 26 Janvier 2012.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
Samsung Medical Center Cardiac & Vascular Center Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Myung-Ho Jeong, Hyo-Soo Kim,
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Case report of FFR for bifurcation Nanjing first hospital Nanjing heart center Yefei chenshaoliang.
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
左主干病变 PCI 中 IVUS 的指导 作用:是否必需? 钱杰阜外心血管病医院. 术前评价 LM 病变.
Treatment of bifurcation lesions is a complex problem Different techniques are commonly used (Y-/T-stenting, „culotte“ technique, „kissing stent“ technique…)
Lianglong Chen MD PhD FACC
Endeavor 4: A Randomized Comparison of a Zotarolimus- Eluting Stent and a Paclitaxel- Eluting Stent in Patients with Coronary Artery Disease Martin B.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Left Main PCI: What is Best Practice? Ayman A. Magd, MD FSCAI Board of Trustees of SCAI Board of Trustees of SCAI Professor of Cardiology, Azhar University.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Left Main PCI: What is Best Practice? Theodore A Bass, MD FSCAI, FACC President-Elect SCAI Professor of Medicine, University of Florida Medical Director.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
IVUS, FFR, OCT- Which Should I Use For PCI?
Clinical Usefulness of Post-Stenting FFR
Complex Coronary Cases
(DES)+BVS +DCB for long diffuse LAD disease
Strategy planning in coronary bifurcation stenting
Bifurcation FFR - Helpful or Wasteful?
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
BVS Expand: First Results of Wide Clinical Applications
Trends in Coronary Procedures per 1000 Medicare Beneficiaries
Unprotected Left Main Intervention How To Perform A Safe PCI
BBK II Trial design: Patients undergoing a two-stent approach for a de novo bifurcation lesion were randomized in a 1:1 fashion to either culotte stenting.
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Left Main PCI: What is Best Practice?
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Bifurcation Disease: Simulation Training Curriculum
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
TAXUS – Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma,
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
SMART-STRATEGY Trial design: Patients with a bifurcation coronary lesion were randomized to a conservative strategy (n = 128) vs. an aggressive strategy.
Impact of Diabetes Mellitus on Long-term Outcomes in the
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
Presentation transcript:

左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University

What do we know about the distal LM? Left main bifurcation: what is the best choice?

Fact #1 – Patients with LM bifurcation lesions have a significantly higher incidence of MACE than patients with ostial and midshaft lesions T-SEARCH/RESEARCH J Am Coll Cardiol 2006;47: month MACE adj. HR 2.79 (95% CI ), p = n = 130 GISE/SICI Eur Heart J 2010;30: month MACE adj. HR 1.50 (95% CI ), p = n = 1,111 Left main bifurcation: what is the best choice?

HR (95% CI)P P Death1.00 ( ) ( )0.21 Q-MI1.42 ( ) ( )0.57 TVR7.71 ( ) ( )< Death, Q-MI or Stroke1.06 ( ) ( )0.62 Death, Q-MI, Stroke or TVR1.51 ( ) ( )0.04 Fact #2 – DES-PCI is associated with a similar higher risk of TVR than CABG either in patients with non-distal or distal LM lesions Ostium/shaftBifurcation Data from the MAIN COMPARE Registry; HR for DES-PCI with reference to CABG Adapted from Park SJ Left main bifurcation: what is the best choice?

SYNTAX Left Main arm What did it add to our understanding on Distal LM PCI? Left main bifurcation: what is the best choice?

Key findings from SYNTAX (LM PCI cohort)  In distal versus non-distal left main lesions:  No difference in safety (death/CVA/MI)  No significant difference in revascularization rates Distal vs non-Distal Left main bifurcation: what is the best choice?

 In distal left main lesions  No difference in safety (death/CVA/MI)  Trend towards higher MACCE driven by more revascularization rate for bifurcation stenting using ≥2 stents versus 1 stent 2-stent vs 1-stent Key findings from SYNTAX (LM PCI cohort) Left main bifurcation: what is the best choice?

 In distal left main lesions  Equivalent safety  Significantly increased MACCE and revascularization with non provisional T-stenting versus T-stenting T-stent vs non T-stent Key findings from SYNTAX (LM PCI cohort) Left main bifurcation: what is the best choice?

But... only 12.7% of the randomized SYNTAX cohort received PCI for a distal LM lesion Huge chance for Type I and Type II errors! Left main bifurcation: what is the best choice?

Beyond the SYNTAX Looking for meaningful predictors of worse outcome relevant to the LM bifurcation cohort  Stenting technique  Plaque distribution and bifurcation angle  SYNTAX score Left main bifurcation: what is the best choice?

MACE free survival (%) Time (months) % 72.0% OSTIUM/SHAFT BIFURCATION P = 0.035* 1) The case for the stenting technique - LM Bifurcations treated with 2 stents have worse outcomes than LM bifurcations treated with 1 stent MACE free survival (%) Time (months) % 67.0% OSTIUM/SHAFT BIFURCATION, 2 stents P = 0.38* BIFURCATION, 1 stent 75.0% P < 0.001** * log rank test for ostium/shaft versus bifurcation 1 stent ** log rank test for ostium/shaft versus bifurcation 2 stents * log rank test for ostium/shaft versus bifurcation Palmerini et al. Eur Heart J 2010;30: GISE/SICI Registry (n = 1,111) Left main bifurcation: what is the best choice?

Worse outcomes of bifurcation LM PCI are driven by need for revascularization, but only in patients receiving 2 stents 2-year MI2-year TLR2-year death2-year cardiac death P < P = NS OSTIUM/SHAFT BIFURCATION, 2 stents BIFURCATION, 1 stent Palmerini et al. Eur Heart J 2010;30: GISE/SICI Registry (n = 1,111) Left main bifurcation: what is the best choice?

Whole Bifurcation (WB) non-Whole Bifurcation (non-WB) Plaque Distribution Pattern in LM Bifurcation Tamburino et al. JACC Interv 2010;3: Left main bifurcation: what is the best choice?

24.9% 8.3% HR: 3.12; 95% CI ; p = 0.001* Adj. HR 2.84; 95% CI , p = Non-WB (n = 145) WB (n = 184) 2) Plaque distribution pattern in LM bifurcation - Three-year TLR stratified by baseline plaque distribution pattern Tamburino et al. JACC Interv 2010;3: Whole Bifurcation (WB)* non-Whole Bifurcation (non-WB) *The presence of the plaque at each side was attributed regardless of the stenosis degree Left main bifurcation: what is the best choice?

P = P = = 0.55 P = year target lesion revascularization (%) P = 0.29 The Impact of Plaque Distribution Pattern is Independent from the Stenting Technique P for interaction between plaque distribution and stent technique: NS Tamburino et al. JACC Interv 2010;3: Left main bifurcation: what is the best choice?

WB Medina non 1,1,1 (66.2%) 1,1,1 Non 1,1,1 20.7% 26.8% P = 0.57 WB lesions only Medina 1,1,1 (33.8%) WB is associated with high TLR regardless of the stenosis degree in each bifurcation segment Tamburino et al. JACC Interv 2010;3: Left main bifurcation: what is the best choice?

7.8% 26.8% P = Medina non 1,1,1 only WB Non WB Medina non 1,1,1 Non-WB WB Tamburino et al. JACC Interv 2010;3: WB is associated with high TLR regardless of the stenosis degree in each bifurcation segment Left main bifurcation: what is the best choice?

Capodanno et al. JACC Interv 2009;2:731-8 Ostium/shaft * After adjusting for confounders: HR 2.89, , p = ** After adjusting for confounders: HR 6.09, , p = P for interaction between SYNTAX score, lesion location and treatment: P = P = 0.001* Bifurcation P = P = 0.006** 3) The case for the downstream CAD - SXscore predicts 2- year cardiac mortality regardless of lesion location Left main bifurcation: what is the best choice?

PCI or CABG? Would you use two stents? No Is the bifurcation fully (even subcritically) involved? Favors CABGConsider PCI Yes No Yes High SYNTAX score? Left main bifurcation: what is the best choice?

Optimal LM Bifurcation PCI Lesion Preparation and DES Implantation Lesion preparation - strongly discourage direct stenting; RA for heavily calcified lesion DES implantation :1 ratio at appropriate pressures for complete apposition…  Strongly recommend IVUS guidance for stent strategy, sizing, and optimal implant results (stent dimensions and apposition) Left main bifurcation: what is the best choice?

Optimal LM Bifurcation PCI IVUS Guidance Strongly recommended to IVUS both LAD and LCx origins and entire LM segment back to ostium, PRIOR to intervention - PLAN STRATEGY In general, LCx ostium lumen area > 4.0 mm 2 or plaque burden ≤ 60% indicates acceptable for one stent strategy Iterative post-dilatation and IVUS to achieve LM MLA > 8.5 mm 2, origin LAD > 5.5 mm 2, and origin LCx >5.5mm 2 (2 stents) or >4.0mm 2 (1 stent) IVUS desirable after kissing balloons, esp. origin LCx (if catheter passes easily) Left main bifurcation: what is the best choice?

Single stent crossover provisional technique is strongly recommended whenever possible; post-dilate LM stent with non-compliant balloon and also dilate origin of sidebranch if patency questioned (? IVUS or FFR), followed by kissing balloons. Provisional second stent - only consider after repetitive kissing balloon inflations: (1) severe dissection (≥ grade B), (2) TIMI flow 70% DS (visual estimate) or IVUS MLA 60% Optimal LM Bifurcation PCI Stent techniques Left main bifurcation: what is the best choice?

Primary two stent technique - should be considered when the sidebranch (usually LCx) is large (> 3 mm), with sidebranch disease and lesion length > 5mm OR special anatomic considerations (e.g. severe calcification); Technique at operator’s discretion (T-stent, TAP, mini-crush, culotte), but V-stenting is discouraged Optimal LM Bifurcation PCI Stent techniques Left main bifurcation: what is the best choice?

Kissing balloon dilatations - strongly recommended, using non-compliant balloons; (1) after crossover single stent at operator’s discretion when sidebranch patency is compromised (2) after primary two stent technique with 2-step strategy - first sidebranch at high pressures, then kissing balloons at moderate pressures Optimal LM Bifurcation PCI Kissing balloon Left main bifurcation: what is the best choice?